Cencora Revenue 2010-2024 | COR
Cencora annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cencora revenue for the quarter ending December 31, 2024 was $81.487B, a 12.78% increase year-over-year.
- Cencora revenue for the twelve months ending December 31, 2024 was $303.193B, a 11.64% increase year-over-year.
- Cencora annual revenue for 2024 was $293.959B, a 12.12% increase from 2023.
- Cencora annual revenue for 2023 was $262.173B, a 9.89% increase from 2022.
- Cencora annual revenue for 2022 was $238.587B, a 11.5% increase from 2021.
| Cencora Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $293,959 |
| 2023 | $262,173 |
| 2022 | $238,587 |
| 2021 | $213,989 |
| 2020 | $189,894 |
| 2019 | $179,589 |
| 2018 | $167,940 |
| 2017 | $153,144 |
| 2016 | $146,850 |
| 2015 | $135,962 |
| 2014 | $119,569 |
| 2013 | $87,959 |
| 2012 | $78,081 |
| 2011 | $78,696 |
| 2010 | $77,776 |
| 2009 | $71,760 |
| Cencora Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-12-31 | $81,487 |
| 2024-09-30 | $79,050 |
| 2024-06-30 | $74,241 |
| 2024-03-31 | $68,414 |
| 2023-12-31 | $72,253 |
| 2023-09-30 | $68,922 |
| 2023-06-30 | $66,947 |
| 2023-03-31 | $63,457 |
| 2022-12-31 | $62,847 |
| 2022-09-30 | $61,174 |
| 2022-06-30 | $60,065 |
| 2022-03-31 | $57,719 |
| 2021-12-31 | $59,629 |
| 2021-09-30 | $58,912 |
| 2021-06-30 | $53,406 |
| 2021-03-31 | $49,154 |
| 2020-12-31 | $52,517 |
| 2020-09-30 | $49,245 |
| 2020-06-30 | $45,367 |
| 2020-03-31 | $47,418 |
| 2019-12-31 | $47,865 |
| 2019-09-30 | $45,638 |
| 2019-06-30 | $45,239 |
| 2019-03-31 | $43,320 |
| 2018-12-31 | $45,392 |
| 2018-09-30 | $43,297 |
| 2018-06-30 | $43,142 |
| 2018-03-31 | $41,034 |
| 2017-12-31 | $40,466 |
| 2017-09-30 | $39,120 |
| 2017-06-30 | $38,707 |
| 2017-03-31 | $37,147 |
| 2016-12-31 | $38,169 |
| 2016-09-30 | $37,561 |
| 2016-06-30 | $36,882 |
| 2016-03-31 | $35,698 |
| 2015-12-31 | $36,709 |
| 2015-09-30 | $35,470 |
| 2015-06-30 | $34,234 |
| 2015-03-31 | $32,669 |
| 2014-12-31 | $33,589 |
| 2014-09-30 | $31,589 |
| 2014-06-30 | $30,348 |
| 2014-03-31 | $28,456 |
| 2013-12-31 | $29,176 |
| 2013-09-30 | $24,469 |
| 2013-06-30 | $21,907 |
| 2013-03-31 | $20,524 |
| 2012-12-31 | $21,060 |
| 2012-09-30 | $18,734 |
| 2012-06-30 | $19,327 |
| 2012-03-31 | $19,708 |
| 2011-12-31 | $20,312 |
| 2011-09-30 | $18,886 |
| 2011-06-30 | $20,161 |
| 2011-03-31 | $19,760 |
| 2010-12-31 | $19,889 |
| 2010-09-30 | $19,538 |
| 2010-06-30 | $19,602 |
| 2010-03-31 | $19,301 |
| 2009-12-31 | $19,336 |
| 2009-09-30 | $18,716 |
| 2009-06-30 | $18,394 |
| 2009-03-31 | $17,312 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $47.211B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.197B | 27.76 |
| Elevance Health (ELV) | United States | $90.566B | 11.84 |
| CVS Health (CVS) | United States | $82.065B | 12.01 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| Natera (NTRA) | United States | $22.205B | 0.00 |
| ICON (ICLR) | Ireland | $16.651B | 14.81 |
| BioMerieux (BMXMF) | France | $14.074B | 0.00 |
| Doximity (DOCS) | United States | $14.002B | 72.82 |
| Revvity (RVTY) | United States | $13.962B | 23.41 |
| Viatris (VTRS) | United States | $13.201B | 4.07 |
| Solventum (SOLV) | United States | $12.870B | 0.00 |
| Avantor (AVTR) | United States | $11.909B | 17.49 |
| CochLear (CHEOY) | Australia | $11.330B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.506B | 27.30 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.794B | 0.00 |
| HealthEquity (HQY) | United States | $9.682B | 48.57 |
| Sonic Healthcare (SKHHY) | Australia | $8.686B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.297B | 15.72 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.601B | 25.63 |
| Organon (OGN) | United States | $4.041B | 4.12 |
| Sotera Health (SHC) | United States | $3.829B | 20.49 |
| BrightSpring Health Services (BTSG) | United States | $3.552B | 75.56 |
| Surgery Partners (SGRY) | United States | $3.263B | 37.20 |
| Concentras Parent (CON) | United States | $2.981B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.791B | 338.60 |
| Alignment Healthcare (ALHC) | United States | $2.755B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.185B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.118B | 0.00 |
| Progyny (PGNY) | United States | $2.033B | 41.17 |
| PACS (PACS) | United States | $2.010B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.852B | 48.60 |
| Premier (PINC) | United States | $1.726B | 11.05 |
| Agilon Health (AGL) | United States | $1.492B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.480B | 12.40 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.254B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.984B | 7.81 |
| Establishment Labs Holdings (ESTA) | $0.981B | 0.00 | |
| Embecta (EMBC) | United States | $0.838B | 5.74 |
| Auna S.A (AUNA) | Luxembourg | $0.611B | 0.00 |
| DocGo (DCGO) | United States | $0.513B | 19.35 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.480B | 0.00 |
| MultiPlan (MPLN) | United States | $0.477B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
| Enhabit (EHAB) | United States | $0.424B | 36.70 |
| Nutex Health (NUTX) | United States | $0.335B | 0.00 |
| LifeMD (LFMD) | United States | $0.326B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.311B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
| Beauty Health (SKIN) | United States | $0.199B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.183B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
| Biodesix (BDSX) | United States | $0.134B | 0.00 |
| So-Young (SY) | China | $0.114B | 19.40 |
| IceCure Medical (ICCM) | Israel | $0.083B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| ModivCare (MODV) | United States | $0.079B | 4.29 |
| Oncology Institute (TOI) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.62 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| OncoCyte (OCX) | United States | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.019B | 0.00 |
| KindlyMD (KDLY) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |